Last updated: 2026-09-09 06:43:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
INVO Fertility, Inc. (IVF) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.98, with a market capitalization of $2.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.90 to $84.40. This page covers its latest market performance, valuation, price trends and company information.
$2.47M | |
$0.99 | |
$384.00 | |
$0.90 | |
-- | |
71.68K | |
4.24M | |
-- | |
$84.40 | |
$0.90 | |
-- | |
-- |
INVO Fertility, Inc. (IVF) last closed at $0.00 as of 2026-09-08 23:50:00, -- from the previous close of $0.00.
During the latest regular trading session, IVF traded between $0.90 and $384.00, with a volume of 71.68K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, INVO Fertility, Inc. (IVF) moved from $1.00 to $0.98, representing a decline of 2.20% ($0.02).
The stock traded between $0.97 and $1.04 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 192.35 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.1%
IVF is currently trading at $0.98, placing it 0.1% of the way from its 52-week low of $0.90 to its 52-week high of $84.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 46 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of INVO Fertility, Inc. (IVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.